Literature DB >> 24821553

Serine 249 phosphorylation by ATM protein kinase regulates hepatocyte nuclear factor-1α transactivation.

Long Zhao1, Hui Chen2, Yi-Qun Zhan2, Chang-Yan Li2, Chang-Hui Ge2, Jian-Hong Zhang1, Xiao-Hui Wang2, Miao Yu3, Xiao-Ming Yang4.   

Abstract

Hepatocyte nuclear factor-1 alpha (HNF1α) exerts important effects on gene expression in multiple tissues. Several studies have directly or indirectly supported the role of phosphorylation processes in the activity of HNF1α. However, the molecular mechanism of this phosphorylation remains largely unknown. Using microcapillary liquid chromatography MS/MS and biochemical assays, we identified a novel phosphorylation site in HNF1α at Ser249. We also found that the ATM protein kinase phosphorylated HNF1α at Ser249 in vitro in an ATM-dependent manner and that ATM inhibitor KU55933 treatment inhibited phosphorylation of HNF1α at Ser249 in vivo. Coimmunoprecipitation assays confirmed the association between HNF1α and ATM. Moreover, ATM enhanced HNF1α transcriptional activity in a dose-dependent manner, whereas the ATM kinase-inactive mutant did not. The use of KU55933 confirmed our observation. Compared with wild-type HNF1α, a mutation in Ser249 resulted in a pronounced decrease in HNF1α transactivation, whereas no dominant-negative effect was observed. The HNF1αSer249 mutant also exhibited normal nuclear localization but decreased DNA-binding activity. Accordingly, the functional studies of HNF1αSer249 mutant revealed a defect in glucose metabolism. Our results suggested that ATM regulates the activity of HNF1α by phosphorylation of serine 249, particularly in glucose metabolism, which provides valuable insights into the undiscovered mechanisms of ATM in the regulation of glucose homeostasis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATM; Glucose metabolism; HNF1α; Phosphorylation; Transcription regulation

Mesh:

Substances:

Year:  2014        PMID: 24821553     DOI: 10.1016/j.bbagrm.2014.05.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription.

Authors:  Cecilia Patitucci; Gabrielle Couchy; Alessia Bagattin; Tatiana Cañeque; Aurélien de Reyniès; Jean-Yves Scoazec; Raphaël Rodriguez; Marco Pontoglio; Jessica Zucman-Rossi; Mario Pende; Ganna Panasyuk
Journal:  J Clin Invest       Date:  2017-04-10       Impact factor: 14.808

2.  The E3 SUMO ligase PIASγ is a novel interaction partner regulating the activity of diabetes associated hepatocyte nuclear factor-1α.

Authors:  Alba Kaci; Magdalena Keindl; Marie H Solheim; Pål R Njølstad; Lise Bjørkhaug; Ingvild Aukrust
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.